SpaceX’s third-generation Starship, which NASA may use to put astronauts on the moon, makes debut

SpaceX completed the 12th Starship test flight, with the 407-foot V3 vehicle reaching the Indian Ocean after deploying 20 mock Starlink satellites and demonstrating several in-flight systems despite partial engine issues. The upgraded rocket is central to NASA’s Artemis moon program, with Starship now one step closer to carrying astronauts to the lunar surface. The article also notes SpaceX is taking reservations for private moon and Mars flights, highlighting continued commercialization potential.

Analysis

The market is likely underpricing how much this changes the pace of lunar infrastructure spend. A more credible Starship reduces execution risk not just for SpaceX, but for the broader Artemis supply chain: propulsion subsystems, cryogenic transfer, guidance software, thermal protection, and launch-range infrastructure all move from speculative to schedule-sensitive contracts over the next 12-24 months. The key second-order effect is that NASA’s “safety-first” procurement process becomes a race between two lander architectures, which should keep capex flowing even if one vendor stumbles.

For competitors, this is structurally negative for any pure-play moonshot narrative that depends on Starship failing. Blue Origin still has optionality, but its valuation case improves only if Starship regresses materially; otherwise it risks becoming the backup plan rather than the winner. The more interesting spillover is into legacy aerospace primes and defense contractors that own the mission-critical subsystems and integration work—those businesses benefit even if SpaceX captures the headlines, because complexity and redundancy are what drives budget expansion.

The contrarian risk is that success here may be a sell-the-news event for private SpaceX-adjacent hype and a valuation headwind for the “everything-to-the-moon” narrative. A public-market listing would force investors to separate launch cadence from profitability, and the path from test success to dependable human-rated operations is still long; one off-nominal landing or pad issue can add 6-12 months to the schedule. The other key watchpoint is policy: if Artemis slips, the market will begin discounting the lunar timeline and re-anchor on defense/LEO applications instead.

From a trading standpoint, the cleaner expression is not to chase SpaceX exposure directly, but to own the enablers with contractual revenue and multiple ways to win. The asymmetric setup is in suppliers and systems integrators that monetize both a SpaceX-led and a Blue Origin-led landing path, while avoiding single-name binary risk tied to test outcomes.

Key Decisions for Investors

• Overweight aerospace/defense enablers with lunar content (LMT, NOC, RTX) on a 6-12 month horizon; the setup is favorable because they get paid regardless of which lander wins, while schedule accelerations can re-rate backlog quality.
• Initiate a relative-value long basket of launch/infrastructure beneficiaries vs. pure lunar speculative names where available; prefer cash-generative primes over high-beta space venture proxies, targeting 15-25% upside with lower drawdown risk.
• If listed SpaceX becomes available, wait for first 2-3 quarters of public guidance before initiating size; any IPO pop is likely to fade once investors focus on margin dilution from R&D and capex intensity.
• Use event-driven long-dated calls on defense names with meaningful space exposure into Artemis milestones over the next 9-18 months; pay up for convexity only if implied vol remains below historical event windows.
• Avoid shorting Blue Origin-related thematic names purely on one Starship success; the better trade is a basket short of moonshot hype where execution is not yet monetized, with a 3-6 month stop if NASA re-accelerates procurement.